Symbol="THRX"
AssetType="Common Stock"
Name="Theseus Pharmaceuticals Inc"
Description="Theseus Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. The company is headquartered in Cambridge, Massachusetts."
CIK="1745020"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="245 MAIN STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="139095000"
EBITDA="-65990000"
PERatio="None"
PEGRatio="None"
BookValue="5.39"
DividendPerShare="0"
DividendYield="0"
EPS="-1.45"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.171"
ReturnOnEquityTTM="-0.25"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.04"
EVToRevenue="-"
EVToEBITDA="-0.229"
Beta="None"
num_52WeekHigh="14.77"
num_52WeekLow="2.62"
num_50DayMovingAverage="5.5"
num_200DayMovingAverage="8.08"
SharesOutstanding="43603400"
DividendDate="None"
ExDividendDate="None"
symbol="THRX"
open="3.16"
high="3.20"
low="3.11"
price="3.15"
volume="38771.00"
latest_trading_day="2023-08-30"
previous_close="3.17"
change="-0.02"
change_percent="-0.6309%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="86"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="484221"
Change_recent_avg="0.01"
Delta_recent_avg="0.59"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="-0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_negative_thumbnail_id_2="1156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="537"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="630"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0078.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
